TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. Recognized by TIME as one of “The 100 Best Inventions of 2020” and named an honoree in the AI and data category for Fast Company’s “2021 World Changing Ideas Awards,” TrialJectory uses artificial intelligence (AI) to inform and empower cancer patients to own their treatment journey. The only offering of its kind, TrialJectory also captures and analyzes real-world patient data that can be used to further evolve the oncology research landscape
https://webapp.trialjectory.com/questionnaire/disease_status